nodes	percent_of_prediction	percent_of_DWPC	metapath
Bosentan—EDNRB—coronary artery disease	0.237	0.569	CbGaD
Bosentan—EDNRA—coronary artery disease	0.18	0.431	CbGaD
Bosentan—EDNRA—Acetylsalicylic acid—coronary artery disease	0.131	0.361	CbGbCtD
Bosentan—ABCB11—Rosuvastatin—coronary artery disease	0.037	0.102	CbGbCtD
Bosentan—ABCB11—Pravastatin—coronary artery disease	0.0337	0.093	CbGbCtD
Bosentan—CYP2C9—Fenofibrate—coronary artery disease	0.0147	0.0404	CbGbCtD
Bosentan—CYP2C9—Gemfibrozil—coronary artery disease	0.0117	0.0323	CbGbCtD
Bosentan—CYP2C9—Clopidogrel—coronary artery disease	0.0102	0.028	CbGbCtD
Bosentan—CYP3A4—Ticagrelor—coronary artery disease	0.00956	0.0264	CbGbCtD
Bosentan—CYP2C9—Pitavastatin—coronary artery disease	0.00888	0.0245	CbGbCtD
Bosentan—CYP2C9—Valsartan—coronary artery disease	0.00863	0.0238	CbGbCtD
Bosentan—CYP3A4—Fenofibrate—coronary artery disease	0.00852	0.0235	CbGbCtD
Bosentan—CYP3A4—Gemfibrozil—coronary artery disease	0.00681	0.0188	CbGbCtD
Bosentan—CYP2C9—Rosuvastatin—coronary artery disease	0.00654	0.0181	CbGbCtD
Bosentan—CYP2C9—Acetylsalicylic acid—coronary artery disease	0.00638	0.0176	CbGbCtD
Bosentan—CYP2C9—Simvastatin—coronary artery disease	0.00608	0.0168	CbGbCtD
Bosentan—CYP2C9—Lovastatin—coronary artery disease	0.00595	0.0164	CbGbCtD
Bosentan—CYP2C9—Pravastatin—coronary artery disease	0.00595	0.0164	CbGbCtD
Bosentan—CYP3A4—Clopidogrel—coronary artery disease	0.0059	0.0163	CbGbCtD
Bosentan—CYP3A4—Eplerenone—coronary artery disease	0.00549	0.0152	CbGbCtD
Bosentan—CYP2C9—Atorvastatin—coronary artery disease	0.00542	0.015	CbGbCtD
Bosentan—CYP2C9—cardial valve—coronary artery disease	0.00514	0.338	CbGeAlD
Bosentan—CYP2C9—Losartan—coronary artery disease	0.00496	0.0137	CbGbCtD
Bosentan—CYP3A4—Enalapril—coronary artery disease	0.00489	0.0135	CbGbCtD
Bosentan—CYP3A4—Ezetimibe—coronary artery disease	0.0038	0.0105	CbGbCtD
Bosentan—CYP3A4—Rosuvastatin—coronary artery disease	0.0038	0.0105	CbGbCtD
Bosentan—CYP3A4—Simvastatin—coronary artery disease	0.00354	0.00976	CbGbCtD
Bosentan—CYP3A4—Pravastatin—coronary artery disease	0.00346	0.00956	CbGbCtD
Bosentan—CYP3A4—Lovastatin—coronary artery disease	0.00346	0.00956	CbGbCtD
Bosentan—CYP3A4—Atorvastatin—coronary artery disease	0.00315	0.0087	CbGbCtD
Bosentan—CYP3A4—Losartan—coronary artery disease	0.00288	0.00796	CbGbCtD
Bosentan—EDNRB—cardiac ventricle—coronary artery disease	0.00158	0.104	CbGeAlD
Bosentan—EDNRB—myocardium—coronary artery disease	0.00149	0.0979	CbGeAlD
Bosentan—EDNRA—cardiac ventricle—coronary artery disease	0.00131	0.0861	CbGeAlD
Bosentan—EDNRA—myocardium—coronary artery disease	0.00123	0.0809	CbGeAlD
Bosentan—EDNRB—heart—coronary artery disease	0.00104	0.0684	CbGeAlD
Bosentan—EDNRB—cardiac atrium—coronary artery disease	0.000889	0.0585	CbGeAlD
Bosentan—EDNRA—heart—coronary artery disease	0.000859	0.0565	CbGeAlD
Bosentan—EDNRA—cardiac atrium—coronary artery disease	0.000735	0.0483	CbGeAlD
Bosentan—CYP2C9—heart—coronary artery disease	0.000284	0.0187	CbGeAlD
Bosentan—CYP2C9—cardiovascular system—coronary artery disease	0.000268	0.0176	CbGeAlD
Bosentan—CYP2C9—blood—coronary artery disease	0.000212	0.014	CbGeAlD
Bosentan—CYP3A4—blood—coronary artery disease	0.000162	0.0106	CbGeAlD
Bosentan—Abdominal pain—Captopril—coronary artery disease	3.35e-05	0.000252	CcSEcCtD
Bosentan—Body temperature increased—Captopril—coronary artery disease	3.35e-05	0.000252	CcSEcCtD
Bosentan—Dizziness—Simvastatin—coronary artery disease	3.34e-05	0.000251	CcSEcCtD
Bosentan—Rash—Ezetimibe—coronary artery disease	3.34e-05	0.000251	CcSEcCtD
Bosentan—Dermatitis—Ezetimibe—coronary artery disease	3.34e-05	0.000251	CcSEcCtD
Bosentan—Discomfort—Timolol—coronary artery disease	3.34e-05	0.00025	CcSEcCtD
Bosentan—Asthenia—Niacin—coronary artery disease	3.33e-05	0.00025	CcSEcCtD
Bosentan—Fatigue—Losartan—coronary artery disease	3.33e-05	0.00025	CcSEcCtD
Bosentan—Headache—Ezetimibe—coronary artery disease	3.32e-05	0.000249	CcSEcCtD
Bosentan—Oedema—Ramipril—coronary artery disease	3.31e-05	0.000248	CcSEcCtD
Bosentan—Anaphylactic shock—Ramipril—coronary artery disease	3.31e-05	0.000248	CcSEcCtD
Bosentan—Vertigo—Lisinopril—coronary artery disease	3.3e-05	0.000248	CcSEcCtD
Bosentan—Dry mouth—Timolol—coronary artery disease	3.3e-05	0.000248	CcSEcCtD
Bosentan—Pain—Losartan—coronary artery disease	3.3e-05	0.000248	CcSEcCtD
Bosentan—Constipation—Losartan—coronary artery disease	3.3e-05	0.000248	CcSEcCtD
Bosentan—Syncope—Lisinopril—coronary artery disease	3.3e-05	0.000248	CcSEcCtD
Bosentan—Vomiting—Eplerenone—coronary artery disease	3.3e-05	0.000248	CcSEcCtD
Bosentan—Leukopenia—Lisinopril—coronary artery disease	3.29e-05	0.000247	CcSEcCtD
Bosentan—Nausea—Fenofibrate—coronary artery disease	3.29e-05	0.000247	CcSEcCtD
Bosentan—Pruritus—Niacin—coronary artery disease	3.28e-05	0.000246	CcSEcCtD
Bosentan—Asthenia—Pravastatin—coronary artery disease	3.28e-05	0.000246	CcSEcCtD
Bosentan—Gastrointestinal pain—Furosemide—coronary artery disease	3.27e-05	0.000246	CcSEcCtD
Bosentan—Rash—Eplerenone—coronary artery disease	3.27e-05	0.000246	CcSEcCtD
Bosentan—Urticaria—Perindopril—coronary artery disease	3.27e-05	0.000245	CcSEcCtD
Bosentan—Hypersensitivity—Trandolapril—coronary artery disease	3.27e-05	0.000245	CcSEcCtD
Bosentan—Dermatitis—Eplerenone—coronary artery disease	3.27e-05	0.000245	CcSEcCtD
Bosentan—Diarrhoea—Valsartan—coronary artery disease	3.27e-05	0.000245	CcSEcCtD
Bosentan—Shock—Ramipril—coronary artery disease	3.26e-05	0.000244	CcSEcCtD
Bosentan—Hypersensitivity—Enalapril—coronary artery disease	3.26e-05	0.000244	CcSEcCtD
Bosentan—Abdominal pain—Perindopril—coronary artery disease	3.25e-05	0.000244	CcSEcCtD
Bosentan—Body temperature increased—Perindopril—coronary artery disease	3.25e-05	0.000244	CcSEcCtD
Bosentan—Palpitations—Lisinopril—coronary artery disease	3.25e-05	0.000244	CcSEcCtD
Bosentan—Diarrhoea—Olmesartan—coronary artery disease	3.25e-05	0.000244	CcSEcCtD
Bosentan—Headache—Eplerenone—coronary artery disease	3.25e-05	0.000244	CcSEcCtD
Bosentan—Nervous system disorder—Ramipril—coronary artery disease	3.25e-05	0.000244	CcSEcCtD
Bosentan—Thrombocytopenia—Ramipril—coronary artery disease	3.24e-05	0.000243	CcSEcCtD
Bosentan—Oedema—Timolol—coronary artery disease	3.24e-05	0.000243	CcSEcCtD
Bosentan—Anaphylactic shock—Timolol—coronary artery disease	3.24e-05	0.000243	CcSEcCtD
Bosentan—Pruritus—Pravastatin—coronary artery disease	3.23e-05	0.000243	CcSEcCtD
Bosentan—Loss of consciousness—Lisinopril—coronary artery disease	3.23e-05	0.000243	CcSEcCtD
Bosentan—Nausea—Clopidogrel—coronary artery disease	3.23e-05	0.000243	CcSEcCtD
Bosentan—Tachycardia—Ramipril—coronary artery disease	3.23e-05	0.000243	CcSEcCtD
Bosentan—Skin disorder—Ramipril—coronary artery disease	3.22e-05	0.000241	CcSEcCtD
Bosentan—Infection—Timolol—coronary artery disease	3.21e-05	0.000241	CcSEcCtD
Bosentan—Vomiting—Simvastatin—coronary artery disease	3.21e-05	0.000241	CcSEcCtD
Bosentan—Hypersensitivity—Telmisartan—coronary artery disease	3.21e-05	0.000241	CcSEcCtD
Bosentan—Cough—Lisinopril—coronary artery disease	3.21e-05	0.000241	CcSEcCtD
Bosentan—Nausea—Lovastatin—coronary artery disease	3.21e-05	0.000241	CcSEcCtD
Bosentan—Hyperhidrosis—Ramipril—coronary artery disease	3.2e-05	0.00024	CcSEcCtD
Bosentan—Rash—Simvastatin—coronary artery disease	3.19e-05	0.000239	CcSEcCtD
Bosentan—Dermatitis—Simvastatin—coronary artery disease	3.18e-05	0.000239	CcSEcCtD
Bosentan—Asthenia—Trandolapril—coronary artery disease	3.18e-05	0.000239	CcSEcCtD
Bosentan—Shock—Timolol—coronary artery disease	3.18e-05	0.000239	CcSEcCtD
Bosentan—Urticaria—Furosemide—coronary artery disease	3.18e-05	0.000239	CcSEcCtD
Bosentan—Diarrhoea—Niacin—coronary artery disease	3.18e-05	0.000238	CcSEcCtD
Bosentan—Nervous system disorder—Timolol—coronary artery disease	3.17e-05	0.000238	CcSEcCtD
Bosentan—Asthenia—Enalapril—coronary artery disease	3.17e-05	0.000238	CcSEcCtD
Bosentan—Headache—Simvastatin—coronary artery disease	3.17e-05	0.000238	CcSEcCtD
Bosentan—Abdominal pain—Furosemide—coronary artery disease	3.16e-05	0.000237	CcSEcCtD
Bosentan—Body temperature increased—Furosemide—coronary artery disease	3.16e-05	0.000237	CcSEcCtD
Bosentan—Gastrointestinal pain—Losartan—coronary artery disease	3.16e-05	0.000237	CcSEcCtD
Bosentan—Dizziness—Valsartan—coronary artery disease	3.16e-05	0.000237	CcSEcCtD
Bosentan—Anorexia—Ramipril—coronary artery disease	3.16e-05	0.000237	CcSEcCtD
Bosentan—Nausea—Ezetimibe—coronary artery disease	3.15e-05	0.000236	CcSEcCtD
Bosentan—Skin disorder—Timolol—coronary artery disease	3.14e-05	0.000236	CcSEcCtD
Bosentan—Dizziness—Olmesartan—coronary artery disease	3.14e-05	0.000236	CcSEcCtD
Bosentan—Pruritus—Trandolapril—coronary artery disease	3.14e-05	0.000236	CcSEcCtD
Bosentan—Arthralgia—Lisinopril—coronary artery disease	3.13e-05	0.000235	CcSEcCtD
Bosentan—Chest pain—Lisinopril—coronary artery disease	3.13e-05	0.000235	CcSEcCtD
Bosentan—Hyperhidrosis—Timolol—coronary artery disease	3.13e-05	0.000235	CcSEcCtD
Bosentan—Asthenia—Telmisartan—coronary artery disease	3.13e-05	0.000235	CcSEcCtD
Bosentan—Pruritus—Enalapril—coronary artery disease	3.13e-05	0.000235	CcSEcCtD
Bosentan—Diarrhoea—Pravastatin—coronary artery disease	3.13e-05	0.000235	CcSEcCtD
Bosentan—Anxiety—Lisinopril—coronary artery disease	3.12e-05	0.000234	CcSEcCtD
Bosentan—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	3.11e-05	0.000233	CcSEcCtD
Bosentan—Discomfort—Lisinopril—coronary artery disease	3.09e-05	0.000232	CcSEcCtD
Bosentan—Hypotension—Ramipril—coronary artery disease	3.09e-05	0.000232	CcSEcCtD
Bosentan—Anorexia—Timolol—coronary artery disease	3.08e-05	0.000232	CcSEcCtD
Bosentan—Pruritus—Telmisartan—coronary artery disease	3.08e-05	0.000232	CcSEcCtD
Bosentan—Nausea—Eplerenone—coronary artery disease	3.08e-05	0.000231	CcSEcCtD
Bosentan—Dizziness—Niacin—coronary artery disease	3.07e-05	0.00023	CcSEcCtD
Bosentan—Urticaria—Losartan—coronary artery disease	3.07e-05	0.00023	CcSEcCtD
Bosentan—Dry mouth—Lisinopril—coronary artery disease	3.06e-05	0.00023	CcSEcCtD
Bosentan—Body temperature increased—Losartan—coronary artery disease	3.05e-05	0.000229	CcSEcCtD
Bosentan—Abdominal pain—Losartan—coronary artery disease	3.05e-05	0.000229	CcSEcCtD
Bosentan—Asthenia—Captopril—coronary artery disease	3.04e-05	0.000228	CcSEcCtD
Bosentan—Diarrhoea—Trandolapril—coronary artery disease	3.04e-05	0.000228	CcSEcCtD
Bosentan—Vomiting—Valsartan—coronary artery disease	3.03e-05	0.000228	CcSEcCtD
Bosentan—Diarrhoea—Enalapril—coronary artery disease	3.02e-05	0.000227	CcSEcCtD
Bosentan—Hypotension—Timolol—coronary artery disease	3.02e-05	0.000227	CcSEcCtD
Bosentan—Dizziness—Pravastatin—coronary artery disease	3.02e-05	0.000227	CcSEcCtD
Bosentan—Vomiting—Olmesartan—coronary artery disease	3.02e-05	0.000227	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Ramipril—coronary artery disease	3.02e-05	0.000226	CcSEcCtD
Bosentan—Rash—Valsartan—coronary artery disease	3.01e-05	0.000226	CcSEcCtD
Bosentan—Dermatitis—Valsartan—coronary artery disease	3.01e-05	0.000226	CcSEcCtD
Bosentan—Nausea—Simvastatin—coronary artery disease	3e-05	0.000225	CcSEcCtD
Bosentan—Oedema—Lisinopril—coronary artery disease	3e-05	0.000225	CcSEcCtD
Bosentan—Anaphylactic shock—Lisinopril—coronary artery disease	3e-05	0.000225	CcSEcCtD
Bosentan—Pruritus—Captopril—coronary artery disease	3e-05	0.000225	CcSEcCtD
Bosentan—Rash—Olmesartan—coronary artery disease	3e-05	0.000225	CcSEcCtD
Bosentan—Insomnia—Ramipril—coronary artery disease	2.99e-05	0.000225	CcSEcCtD
Bosentan—Dermatitis—Olmesartan—coronary artery disease	2.99e-05	0.000225	CcSEcCtD
Bosentan—Headache—Valsartan—coronary artery disease	2.99e-05	0.000224	CcSEcCtD
Bosentan—Diarrhoea—Telmisartan—coronary artery disease	2.98e-05	0.000224	CcSEcCtD
Bosentan—Infection—Lisinopril—coronary artery disease	2.98e-05	0.000224	CcSEcCtD
Bosentan—Headache—Olmesartan—coronary artery disease	2.98e-05	0.000223	CcSEcCtD
Bosentan—Paraesthesia—Ramipril—coronary artery disease	2.97e-05	0.000223	CcSEcCtD
Bosentan—Shock—Lisinopril—coronary artery disease	2.95e-05	0.000222	CcSEcCtD
Bosentan—Asthenia—Perindopril—coronary artery disease	2.95e-05	0.000222	CcSEcCtD
Bosentan—Dyspnoea—Ramipril—coronary artery disease	2.95e-05	0.000222	CcSEcCtD
Bosentan—Vomiting—Niacin—coronary artery disease	2.95e-05	0.000222	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Timolol—coronary artery disease	2.95e-05	0.000221	CcSEcCtD
Bosentan—Hypersensitivity—Furosemide—coronary artery disease	2.95e-05	0.000221	CcSEcCtD
Bosentan—Somnolence—Ramipril—coronary artery disease	2.94e-05	0.000221	CcSEcCtD
Bosentan—Thrombocytopenia—Lisinopril—coronary artery disease	2.94e-05	0.000221	CcSEcCtD
Bosentan—Dizziness—Trandolapril—coronary artery disease	2.93e-05	0.00022	CcSEcCtD
Bosentan—Tachycardia—Lisinopril—coronary artery disease	2.93e-05	0.00022	CcSEcCtD
Bosentan—Insomnia—Timolol—coronary artery disease	2.93e-05	0.00022	CcSEcCtD
Bosentan—Rash—Niacin—coronary artery disease	2.93e-05	0.00022	CcSEcCtD
Bosentan—Dermatitis—Niacin—coronary artery disease	2.92e-05	0.000219	CcSEcCtD
Bosentan—Dizziness—Enalapril—coronary artery disease	2.92e-05	0.000219	CcSEcCtD
Bosentan—Skin disorder—Lisinopril—coronary artery disease	2.92e-05	0.000219	CcSEcCtD
Bosentan—Dyspepsia—Ramipril—coronary artery disease	2.91e-05	0.000219	CcSEcCtD
Bosentan—Pruritus—Perindopril—coronary artery disease	2.91e-05	0.000219	CcSEcCtD
Bosentan—Headache—Niacin—coronary artery disease	2.91e-05	0.000218	CcSEcCtD
Bosentan—Paraesthesia—Timolol—coronary artery disease	2.91e-05	0.000218	CcSEcCtD
Bosentan—Vomiting—Pravastatin—coronary artery disease	2.91e-05	0.000218	CcSEcCtD
Bosentan—Hyperhidrosis—Lisinopril—coronary artery disease	2.9e-05	0.000218	CcSEcCtD
Bosentan—Diarrhoea—Captopril—coronary artery disease	2.9e-05	0.000218	CcSEcCtD
Bosentan—Dyspnoea—Timolol—coronary artery disease	2.89e-05	0.000217	CcSEcCtD
Bosentan—Dizziness—Telmisartan—coronary artery disease	2.88e-05	0.000216	CcSEcCtD
Bosentan—Rash—Pravastatin—coronary artery disease	2.88e-05	0.000216	CcSEcCtD
Bosentan—Dermatitis—Pravastatin—coronary artery disease	2.88e-05	0.000216	CcSEcCtD
Bosentan—Decreased appetite—Ramipril—coronary artery disease	2.88e-05	0.000216	CcSEcCtD
Bosentan—Somnolence—Timolol—coronary artery disease	2.88e-05	0.000216	CcSEcCtD
Bosentan—Asthenia—Furosemide—coronary artery disease	2.87e-05	0.000215	CcSEcCtD
Bosentan—Headache—Pravastatin—coronary artery disease	2.86e-05	0.000215	CcSEcCtD
Bosentan—Anorexia—Lisinopril—coronary artery disease	2.86e-05	0.000215	CcSEcCtD
Bosentan—Gastrointestinal disorder—Ramipril—coronary artery disease	2.86e-05	0.000215	CcSEcCtD
Bosentan—Fatigue—Ramipril—coronary artery disease	2.85e-05	0.000214	CcSEcCtD
Bosentan—Dyspepsia—Timolol—coronary artery disease	2.85e-05	0.000214	CcSEcCtD
Bosentan—Hypersensitivity—Losartan—coronary artery disease	2.84e-05	0.000213	CcSEcCtD
Bosentan—Nausea—Valsartan—coronary artery disease	2.84e-05	0.000213	CcSEcCtD
Bosentan—Pruritus—Furosemide—coronary artery disease	2.83e-05	0.000212	CcSEcCtD
Bosentan—Constipation—Ramipril—coronary artery disease	2.83e-05	0.000212	CcSEcCtD
Bosentan—Nausea—Olmesartan—coronary artery disease	2.82e-05	0.000212	CcSEcCtD
Bosentan—Vomiting—Trandolapril—coronary artery disease	2.82e-05	0.000212	CcSEcCtD
Bosentan—Diarrhoea—Perindopril—coronary artery disease	2.82e-05	0.000211	CcSEcCtD
Bosentan—Decreased appetite—Timolol—coronary artery disease	2.81e-05	0.000211	CcSEcCtD
Bosentan—Vomiting—Enalapril—coronary artery disease	2.81e-05	0.000211	CcSEcCtD
Bosentan—Hypotension—Lisinopril—coronary artery disease	2.81e-05	0.000211	CcSEcCtD
Bosentan—Dizziness—Captopril—coronary artery disease	2.8e-05	0.00021	CcSEcCtD
Bosentan—Rash—Trandolapril—coronary artery disease	2.8e-05	0.00021	CcSEcCtD
Bosentan—Dermatitis—Trandolapril—coronary artery disease	2.8e-05	0.00021	CcSEcCtD
Bosentan—Gastrointestinal disorder—Timolol—coronary artery disease	2.79e-05	0.00021	CcSEcCtD
Bosentan—Fatigue—Timolol—coronary artery disease	2.79e-05	0.000209	CcSEcCtD
Bosentan—Rash—Enalapril—coronary artery disease	2.79e-05	0.000209	CcSEcCtD
Bosentan—Dermatitis—Enalapril—coronary artery disease	2.78e-05	0.000209	CcSEcCtD
Bosentan—Headache—Trandolapril—coronary artery disease	2.78e-05	0.000209	CcSEcCtD
Bosentan—Vomiting—Telmisartan—coronary artery disease	2.77e-05	0.000208	CcSEcCtD
Bosentan—Asthenia—Losartan—coronary artery disease	2.77e-05	0.000208	CcSEcCtD
Bosentan—Headache—Enalapril—coronary artery disease	2.77e-05	0.000208	CcSEcCtD
Bosentan—Pain—Timolol—coronary artery disease	2.77e-05	0.000208	CcSEcCtD
Bosentan—Nausea—Niacin—coronary artery disease	2.76e-05	0.000207	CcSEcCtD
Bosentan—Rash—Telmisartan—coronary artery disease	2.75e-05	0.000206	CcSEcCtD
Bosentan—Dermatitis—Telmisartan—coronary artery disease	2.75e-05	0.000206	CcSEcCtD
Bosentan—Diarrhoea—Furosemide—coronary artery disease	2.74e-05	0.000205	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Lisinopril—coronary artery disease	2.74e-05	0.000205	CcSEcCtD
Bosentan—Pruritus—Losartan—coronary artery disease	2.73e-05	0.000205	CcSEcCtD
Bosentan—Headache—Telmisartan—coronary artery disease	2.73e-05	0.000205	CcSEcCtD
Bosentan—Dizziness—Perindopril—coronary artery disease	2.72e-05	0.000204	CcSEcCtD
Bosentan—Insomnia—Lisinopril—coronary artery disease	2.72e-05	0.000204	CcSEcCtD
Bosentan—Nausea—Pravastatin—coronary artery disease	2.71e-05	0.000204	CcSEcCtD
Bosentan—Gastrointestinal pain—Ramipril—coronary artery disease	2.71e-05	0.000203	CcSEcCtD
Bosentan—Paraesthesia—Lisinopril—coronary artery disease	2.7e-05	0.000202	CcSEcCtD
Bosentan—Vomiting—Captopril—coronary artery disease	2.7e-05	0.000202	CcSEcCtD
Bosentan—Dyspnoea—Lisinopril—coronary artery disease	2.68e-05	0.000201	CcSEcCtD
Bosentan—Rash—Captopril—coronary artery disease	2.67e-05	0.000201	CcSEcCtD
Bosentan—Dermatitis—Captopril—coronary artery disease	2.67e-05	0.0002	CcSEcCtD
Bosentan—Somnolence—Lisinopril—coronary artery disease	2.67e-05	0.0002	CcSEcCtD
Bosentan—Headache—Captopril—coronary artery disease	2.66e-05	0.000199	CcSEcCtD
Bosentan—Gastrointestinal pain—Timolol—coronary artery disease	2.65e-05	0.000199	CcSEcCtD
Bosentan—Dizziness—Furosemide—coronary artery disease	2.65e-05	0.000199	CcSEcCtD
Bosentan—Dyspepsia—Lisinopril—coronary artery disease	2.64e-05	0.000198	CcSEcCtD
Bosentan—Diarrhoea—Losartan—coronary artery disease	2.64e-05	0.000198	CcSEcCtD
Bosentan—Nausea—Trandolapril—coronary artery disease	2.64e-05	0.000198	CcSEcCtD
Bosentan—Urticaria—Ramipril—coronary artery disease	2.63e-05	0.000197	CcSEcCtD
Bosentan—Nausea—Enalapril—coronary artery disease	2.63e-05	0.000197	CcSEcCtD
Bosentan—Vomiting—Perindopril—coronary artery disease	2.62e-05	0.000196	CcSEcCtD
Bosentan—Abdominal pain—Ramipril—coronary artery disease	2.62e-05	0.000196	CcSEcCtD
Bosentan—Body temperature increased—Ramipril—coronary artery disease	2.62e-05	0.000196	CcSEcCtD
Bosentan—Decreased appetite—Lisinopril—coronary artery disease	2.61e-05	0.000196	CcSEcCtD
Bosentan—Rash—Perindopril—coronary artery disease	2.6e-05	0.000195	CcSEcCtD
Bosentan—Dermatitis—Perindopril—coronary artery disease	2.59e-05	0.000195	CcSEcCtD
Bosentan—Gastrointestinal disorder—Lisinopril—coronary artery disease	2.59e-05	0.000195	CcSEcCtD
Bosentan—Nausea—Telmisartan—coronary artery disease	2.59e-05	0.000194	CcSEcCtD
Bosentan—Fatigue—Lisinopril—coronary artery disease	2.59e-05	0.000194	CcSEcCtD
Bosentan—Headache—Perindopril—coronary artery disease	2.58e-05	0.000194	CcSEcCtD
Bosentan—Urticaria—Timolol—coronary artery disease	2.57e-05	0.000193	CcSEcCtD
Bosentan—Constipation—Lisinopril—coronary artery disease	2.57e-05	0.000193	CcSEcCtD
Bosentan—Pain—Lisinopril—coronary artery disease	2.57e-05	0.000193	CcSEcCtD
Bosentan—Abdominal pain—Timolol—coronary artery disease	2.56e-05	0.000192	CcSEcCtD
Bosentan—Body temperature increased—Timolol—coronary artery disease	2.56e-05	0.000192	CcSEcCtD
Bosentan—Dizziness—Losartan—coronary artery disease	2.55e-05	0.000192	CcSEcCtD
Bosentan—Vomiting—Furosemide—coronary artery disease	2.54e-05	0.000191	CcSEcCtD
Bosentan—Rash—Furosemide—coronary artery disease	2.52e-05	0.000189	CcSEcCtD
Bosentan—Dermatitis—Furosemide—coronary artery disease	2.52e-05	0.000189	CcSEcCtD
Bosentan—Nausea—Captopril—coronary artery disease	2.52e-05	0.000189	CcSEcCtD
Bosentan—Headache—Furosemide—coronary artery disease	2.51e-05	0.000188	CcSEcCtD
Bosentan—Gastrointestinal pain—Lisinopril—coronary artery disease	2.45e-05	0.000184	CcSEcCtD
Bosentan—Vomiting—Losartan—coronary artery disease	2.45e-05	0.000184	CcSEcCtD
Bosentan—Nausea—Perindopril—coronary artery disease	2.44e-05	0.000184	CcSEcCtD
Bosentan—Hypersensitivity—Ramipril—coronary artery disease	2.44e-05	0.000183	CcSEcCtD
Bosentan—Rash—Losartan—coronary artery disease	2.43e-05	0.000183	CcSEcCtD
Bosentan—Dermatitis—Losartan—coronary artery disease	2.43e-05	0.000183	CcSEcCtD
Bosentan—Headache—Losartan—coronary artery disease	2.42e-05	0.000182	CcSEcCtD
Bosentan—Urticaria—Lisinopril—coronary artery disease	2.38e-05	0.000179	CcSEcCtD
Bosentan—Hypersensitivity—Timolol—coronary artery disease	2.38e-05	0.000179	CcSEcCtD
Bosentan—Nausea—Furosemide—coronary artery disease	2.38e-05	0.000178	CcSEcCtD
Bosentan—Asthenia—Ramipril—coronary artery disease	2.37e-05	0.000178	CcSEcCtD
Bosentan—Abdominal pain—Lisinopril—coronary artery disease	2.37e-05	0.000178	CcSEcCtD
Bosentan—Body temperature increased—Lisinopril—coronary artery disease	2.37e-05	0.000178	CcSEcCtD
Bosentan—Pruritus—Ramipril—coronary artery disease	2.34e-05	0.000176	CcSEcCtD
Bosentan—Asthenia—Timolol—coronary artery disease	2.32e-05	0.000174	CcSEcCtD
Bosentan—Nausea—Losartan—coronary artery disease	2.29e-05	0.000172	CcSEcCtD
Bosentan—Pruritus—Timolol—coronary artery disease	2.29e-05	0.000172	CcSEcCtD
Bosentan—Diarrhoea—Ramipril—coronary artery disease	2.26e-05	0.00017	CcSEcCtD
Bosentan—Diarrhoea—Timolol—coronary artery disease	2.21e-05	0.000166	CcSEcCtD
Bosentan—Hypersensitivity—Lisinopril—coronary artery disease	2.21e-05	0.000166	CcSEcCtD
Bosentan—Dizziness—Ramipril—coronary artery disease	2.19e-05	0.000164	CcSEcCtD
Bosentan—Asthenia—Lisinopril—coronary artery disease	2.15e-05	0.000162	CcSEcCtD
Bosentan—Dizziness—Timolol—coronary artery disease	2.14e-05	0.000161	CcSEcCtD
Bosentan—Pruritus—Lisinopril—coronary artery disease	2.12e-05	0.000159	CcSEcCtD
Bosentan—Vomiting—Ramipril—coronary artery disease	2.1e-05	0.000158	CcSEcCtD
Bosentan—Rash—Ramipril—coronary artery disease	2.09e-05	0.000157	CcSEcCtD
Bosentan—Dermatitis—Ramipril—coronary artery disease	2.09e-05	0.000157	CcSEcCtD
Bosentan—Headache—Ramipril—coronary artery disease	2.07e-05	0.000156	CcSEcCtD
Bosentan—Vomiting—Timolol—coronary artery disease	2.06e-05	0.000154	CcSEcCtD
Bosentan—Diarrhoea—Lisinopril—coronary artery disease	2.05e-05	0.000154	CcSEcCtD
Bosentan—Rash—Timolol—coronary artery disease	2.04e-05	0.000153	CcSEcCtD
Bosentan—Dermatitis—Timolol—coronary artery disease	2.04e-05	0.000153	CcSEcCtD
Bosentan—Headache—Timolol—coronary artery disease	2.03e-05	0.000152	CcSEcCtD
Bosentan—Dizziness—Lisinopril—coronary artery disease	1.99e-05	0.000149	CcSEcCtD
Bosentan—Nausea—Ramipril—coronary artery disease	1.97e-05	0.000148	CcSEcCtD
Bosentan—Nausea—Timolol—coronary artery disease	1.92e-05	0.000144	CcSEcCtD
Bosentan—Vomiting—Lisinopril—coronary artery disease	1.91e-05	0.000143	CcSEcCtD
Bosentan—Rash—Lisinopril—coronary artery disease	1.89e-05	0.000142	CcSEcCtD
Bosentan—Dermatitis—Lisinopril—coronary artery disease	1.89e-05	0.000142	CcSEcCtD
Bosentan—Headache—Lisinopril—coronary artery disease	1.88e-05	0.000141	CcSEcCtD
Bosentan—Nausea—Lisinopril—coronary artery disease	1.78e-05	0.000134	CcSEcCtD
Bosentan—CYP2C9—Metabolism—PFKFB3—coronary artery disease	6.14e-06	8.45e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GSTM2—coronary artery disease	6.14e-06	8.45e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PLIN1—coronary artery disease	6.14e-06	8.45e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—COX5B—coronary artery disease	6.14e-06	8.45e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—DLAT—coronary artery disease	6.14e-06	8.45e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—UQCRFS1—coronary artery disease	6.11e-06	8.41e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PPAP2B—coronary artery disease	6.11e-06	8.41e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CKM—coronary artery disease	6.11e-06	8.41e-05	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—LPL—coronary artery disease	6.11e-06	8.41e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—KIT—coronary artery disease	5.99e-06	8.26e-05	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—AKT1—coronary artery disease	5.96e-06	8.21e-05	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—GPX1—coronary artery disease	5.96e-06	8.21e-05	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CASP3—coronary artery disease	5.9e-06	8.13e-05	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—IL6—coronary artery disease	5.86e-06	8.08e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—coronary artery disease	5.83e-06	8.04e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—SULT1E1—coronary artery disease	5.82e-06	8.01e-05	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—CD36—coronary artery disease	5.8e-06	7.99e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—GSK3B—coronary artery disease	5.75e-06	7.92e-05	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CCND1—coronary artery disease	5.75e-06	7.91e-05	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—PPP2CA—coronary artery disease	5.73e-06	7.89e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—POMC—coronary artery disease	5.71e-06	7.86e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CREB1—coronary artery disease	5.71e-06	7.86e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PYGM—coronary artery disease	5.68e-06	7.82e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ALDH6A1—coronary artery disease	5.68e-06	7.82e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PDK4—coronary artery disease	5.68e-06	7.82e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CKMT2—coronary artery disease	5.68e-06	7.82e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—SULT4A1—coronary artery disease	5.68e-06	7.82e-05	CbGpPWpGaD
Bosentan—CYP3A4—Biological oxidations—POMC—coronary artery disease	5.66e-06	7.8e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—coronary artery disease	5.65e-06	7.78e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CCL2—coronary artery disease	5.58e-06	7.69e-05	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—MMP9—coronary artery disease	5.58e-06	7.68e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—IL6R—coronary artery disease	5.57e-06	7.67e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—HK2—coronary artery disease	5.55e-06	7.64e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—AKR1B1—coronary artery disease	5.55e-06	7.64e-05	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—MTHFR—coronary artery disease	5.5e-06	7.57e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—IGF1—coronary artery disease	5.49e-06	7.56e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—MAPK1—coronary artery disease	5.46e-06	7.52e-05	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—AKT1—coronary artery disease	5.41e-06	7.45e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—SLC27A1—coronary artery disease	5.32e-06	7.33e-05	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—AGT—coronary artery disease	5.22e-06	7.2e-05	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—PIK3CA—coronary artery disease	5.22e-06	7.19e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—LCAT—coronary artery disease	5.22e-06	7.19e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CPT1B—coronary artery disease	5.22e-06	7.19e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—SERPINE1—coronary artery disease	5.21e-06	7.18e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—APOA4—coronary artery disease	5.12e-06	7.05e-05	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—APOE—coronary artery disease	5.12e-06	7.05e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—HMGCS2—coronary artery disease	5.06e-06	6.97e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GYG1—coronary artery disease	5.06e-06	6.97e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PFKM—coronary artery disease	5.06e-06	6.97e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—LDHA—coronary artery disease	5.06e-06	6.97e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GK—coronary artery disease	5.06e-06	6.97e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GATM—coronary artery disease	5.06e-06	6.97e-05	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—APOA1—coronary artery disease	5.06e-06	6.97e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—FGF2—coronary artery disease	5.05e-06	6.95e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—coronary artery disease	5.03e-06	6.93e-05	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—VEGFA—coronary artery disease	5.01e-06	6.9e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—NOS3—coronary artery disease	4.98e-06	6.85e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PDHA1—coronary artery disease	4.95e-06	6.81e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GCLM—coronary artery disease	4.95e-06	6.81e-05	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	4.85e-06	6.67e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—JAK2—coronary artery disease	4.84e-06	6.66e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—AK1—coronary artery disease	4.83e-06	6.65e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GCH1—coronary artery disease	4.83e-06	6.65e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—APOB—coronary artery disease	4.79e-06	6.6e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—TXNRD1—coronary artery disease	4.79e-06	6.6e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CYP11B2—coronary artery disease	4.79e-06	6.6e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—PIK3CA—coronary artery disease	4.74e-06	6.53e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—SLC22A3—coronary artery disease	4.72e-06	6.5e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—HADH—coronary artery disease	4.65e-06	6.41e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ARNTL—coronary artery disease	4.65e-06	6.41e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—MDH2—coronary artery disease	4.63e-06	6.38e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—UGCG—coronary artery disease	4.63e-06	6.38e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PLCD1—coronary artery disease	4.63e-06	6.38e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PPAT—coronary artery disease	4.63e-06	6.38e-05	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—TGFB1—coronary artery disease	4.6e-06	6.33e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—LPL—coronary artery disease	4.58e-06	6.31e-05	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—MAPK1—coronary artery disease	4.51e-06	6.21e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—coronary artery disease	4.47e-06	6.15e-05	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—PPARG—coronary artery disease	4.46e-06	6.14e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PGM1—coronary artery disease	4.46e-06	6.14e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CXCL8—coronary artery disease	4.41e-06	6.08e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—APOA2—coronary artery disease	4.41e-06	6.07e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GPX2—coronary artery disease	4.41e-06	6.07e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PLA2G2A—coronary artery disease	4.41e-06	6.07e-05	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—POMC—coronary artery disease	4.4e-06	6.06e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GPX4—coronary artery disease	4.35e-06	6e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—HK1—coronary artery disease	4.35e-06	6e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—SULT1A1—coronary artery disease	4.35e-06	6e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ABCG5—coronary artery disease	4.35e-06	6e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—CD36—coronary artery disease	4.35e-06	5.99e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PYGB—coronary artery disease	4.3e-06	5.93e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CKB—coronary artery disease	4.3e-06	5.93e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—HADHA—coronary artery disease	4.3e-06	5.93e-05	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—AKT1—coronary artery disease	4.26e-06	5.87e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GSTA1—coronary artery disease	4.25e-06	5.86e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CASP3—coronary artery disease	4.22e-06	5.82e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—LPA—coronary artery disease	4.21e-06	5.79e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—IL6—coronary artery disease	4.2e-06	5.78e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CCND1—coronary artery disease	4.11e-06	5.66e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PLCB3—coronary artery disease	4.07e-06	5.61e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—DLAT—coronary artery disease	4.05e-06	5.57e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PFKFB3—coronary artery disease	4.05e-06	5.57e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GSTM2—coronary artery disease	4.05e-06	5.57e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PLIN1—coronary artery disease	4.05e-06	5.57e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—COX5B—coronary artery disease	4.05e-06	5.57e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—APOA5—coronary artery disease	4.03e-06	5.55e-05	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—ALB—coronary artery disease	4.01e-06	5.52e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—MMP9—coronary artery disease	3.99e-06	5.5e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—P4HB—coronary artery disease	3.95e-06	5.45e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—AGT—coronary artery disease	3.92e-06	5.39e-05	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—PIK3CA—coronary artery disease	3.91e-06	5.39e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PLA2G1B—coronary artery disease	3.88e-06	5.35e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—AKT1—coronary artery disease	3.87e-06	5.33e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	3.84e-06	5.29e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—SULT1E1—coronary artery disease	3.84e-06	5.28e-05	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—NOS3—coronary artery disease	3.83e-06	5.28e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	3.79e-06	5.23e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—HK2—coronary artery disease	3.66e-06	5.04e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—AKR1B1—coronary artery disease	3.66e-06	5.04e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—VCAN—coronary artery disease	3.66e-06	5.04e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ALDOA—coronary artery disease	3.63e-06	5e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—VEGFA—coronary artery disease	3.58e-06	4.94e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—DCN—coronary artery disease	3.52e-06	4.85e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—SLC27A1—coronary artery disease	3.51e-06	4.83e-05	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—PTGS2—coronary artery disease	3.51e-06	4.83e-05	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—IL6—coronary artery disease	3.46e-06	4.77e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—LCAT—coronary artery disease	3.44e-06	4.74e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CPT1B—coronary artery disease	3.44e-06	4.74e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ALDH2—coronary artery disease	3.43e-06	4.72e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—APOA4—coronary artery disease	3.38e-06	4.65e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	3.34e-06	4.6e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—LIPC—coronary artery disease	3.34e-06	4.6e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—HBA1—coronary artery disease	3.34e-06	4.6e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CYP2C19—coronary artery disease	3.34e-06	4.6e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PIK3C2A—coronary artery disease	3.34e-06	4.6e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—APOC3—coronary artery disease	3.32e-06	4.57e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—LDLR—coronary artery disease	3.3e-06	4.55e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	3.3e-06	4.54e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—TGFB1—coronary artery disease	3.29e-06	4.53e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PDHA1—coronary artery disease	3.26e-06	4.49e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GCLM—coronary artery disease	3.26e-06	4.49e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GSTT1—coronary artery disease	3.26e-06	4.49e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—SLC9A1—coronary artery disease	3.26e-06	4.49e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—MAPK1—coronary artery disease	3.23e-06	4.44e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GCLC—coronary artery disease	3.22e-06	4.44e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CETP—coronary artery disease	3.22e-06	4.44e-05	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—AKT1—coronary artery disease	3.2e-06	4.4e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—SDC1—coronary artery disease	3.19e-06	4.39e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—TXNRD1—coronary artery disease	3.16e-06	4.35e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CYP11B2—coronary artery disease	3.16e-06	4.35e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—SLC22A3—coronary artery disease	3.11e-06	4.29e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—HADH—coronary artery disease	3.07e-06	4.22e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ARNTL—coronary artery disease	3.07e-06	4.22e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PSMB5—coronary artery disease	3.01e-06	4.15e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PSMA6—coronary artery disease	3.01e-06	4.15e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	3.01e-06	4.14e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CTGF—coronary artery disease	2.94e-06	4.05e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GOT2—coronary artery disease	2.91e-06	4.02e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—HMGCR—coronary artery disease	2.91e-06	4.02e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—APOA2—coronary artery disease	2.91e-06	4e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	2.91e-06	4e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GPX2—coronary artery disease	2.91e-06	4e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ABCG5—coronary artery disease	2.87e-06	3.96e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—SULT1A1—coronary artery disease	2.87e-06	3.96e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GPX4—coronary artery disease	2.87e-06	3.96e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—HK1—coronary artery disease	2.87e-06	3.96e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—HADHA—coronary artery disease	2.84e-06	3.91e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GSTA1—coronary artery disease	2.8e-06	3.86e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—PIK3CA—coronary artery disease	2.8e-06	3.86e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—LPA—coronary artery disease	2.77e-06	3.82e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PLCB3—coronary artery disease	2.69e-06	3.7e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PLCB1—coronary artery disease	2.68e-06	3.69e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—APOA5—coronary artery disease	2.66e-06	3.66e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	2.63e-06	3.62e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—P4HB—coronary artery disease	2.61e-06	3.59e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ABCA1—coronary artery disease	2.6e-06	3.58e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	2.56e-06	3.53e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GOT1—coronary artery disease	2.52e-06	3.47e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GGT1—coronary artery disease	2.52e-06	3.47e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—IL6—coronary artery disease	2.48e-06	3.42e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—VCAN—coronary artery disease	2.41e-06	3.32e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ALDOA—coronary artery disease	2.39e-06	3.3e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—DCN—coronary artery disease	2.32e-06	3.2e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—AKT1—coronary artery disease	2.29e-06	3.15e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ALDH2—coronary artery disease	2.26e-06	3.11e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GSTP1—coronary artery disease	2.26e-06	3.11e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PPARGC1A—coronary artery disease	2.24e-06	3.08e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—HMOX1—coronary artery disease	2.23e-06	3.07e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—HBA1—coronary artery disease	2.2e-06	3.03e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	2.2e-06	3.03e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CYP2C19—coronary artery disease	2.2e-06	3.03e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—LIPC—coronary artery disease	2.2e-06	3.03e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CAT—coronary artery disease	2.2e-06	3.03e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—APOC3—coronary artery disease	2.19e-06	3.02e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—LDLR—coronary artery disease	2.18e-06	3e-05	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—PIK3CA—coronary artery disease	2.16e-06	2.97e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GSTT1—coronary artery disease	2.15e-06	2.96e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—SLC9A1—coronary artery disease	2.15e-06	2.96e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—APOB—coronary artery disease	2.14e-06	2.94e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CETP—coronary artery disease	2.13e-06	2.93e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GCLC—coronary artery disease	2.13e-06	2.93e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—SDC1—coronary artery disease	2.1e-06	2.9e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GSTM1—coronary artery disease	2.08e-06	2.86e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—LPL—coronary artery disease	2.04e-06	2.81e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GPX1—coronary artery disease	1.99e-06	2.74e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PSMA6—coronary artery disease	1.99e-06	2.74e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PSMB5—coronary artery disease	1.99e-06	2.74e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CTGF—coronary artery disease	1.94e-06	2.67e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CD36—coronary artery disease	1.94e-06	2.67e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—HMGCR—coronary artery disease	1.92e-06	2.65e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GOT2—coronary artery disease	1.92e-06	2.65e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PPP2CA—coronary artery disease	1.91e-06	2.63e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—MTHFR—coronary artery disease	1.84e-06	2.53e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PLCB1—coronary artery disease	1.77e-06	2.43e-05	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—AKT1—coronary artery disease	1.76e-06	2.43e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—AGT—coronary artery disease	1.74e-06	2.4e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ABCA1—coronary artery disease	1.71e-06	2.36e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—APOE—coronary artery disease	1.71e-06	2.35e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—APOA1—coronary artery disease	1.69e-06	2.33e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GGT1—coronary artery disease	1.66e-06	2.29e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GOT1—coronary artery disease	1.66e-06	2.29e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.62e-06	2.23e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GSTP1—coronary artery disease	1.49e-06	2.05e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PPARG—coronary artery disease	1.49e-06	2.05e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	1.48e-06	2.03e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—HMOX1—coronary artery disease	1.47e-06	2.02e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—POMC—coronary artery disease	1.47e-06	2.02e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CAT—coronary artery disease	1.45e-06	2e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—APOB—coronary artery disease	1.41e-06	1.94e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GSTM1—coronary artery disease	1.37e-06	1.89e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—LPL—coronary artery disease	1.34e-06	1.85e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ALB—coronary artery disease	1.34e-06	1.84e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GPX1—coronary artery disease	1.31e-06	1.81e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—NOS3—coronary artery disease	1.28e-06	1.76e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CD36—coronary artery disease	1.28e-06	1.76e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PPP2CA—coronary artery disease	1.26e-06	1.74e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—MTHFR—coronary artery disease	1.21e-06	1.67e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PTGS2—coronary artery disease	1.17e-06	1.61e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—AGT—coronary artery disease	1.15e-06	1.58e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—APOE—coronary artery disease	1.13e-06	1.55e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—APOA1—coronary artery disease	1.11e-06	1.53e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PPARG—coronary artery disease	9.82e-07	1.35e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—POMC—coronary artery disease	9.68e-07	1.33e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ALB—coronary artery disease	8.83e-07	1.22e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—NOS3—coronary artery disease	8.44e-07	1.16e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PTGS2—coronary artery disease	7.72e-07	1.06e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PIK3CA—coronary artery disease	7.2e-07	9.92e-06	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—AKT1—coronary artery disease	5.89e-07	8.11e-06	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PIK3CA—coronary artery disease	4.75e-07	6.54e-06	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—AKT1—coronary artery disease	3.88e-07	5.35e-06	CbGpPWpGaD
